Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
deals
life sciences
national blog main
new york blog main
san francisco blog main
startups
vc
3
×
boston
national top stories
new york top stories
san diego blog main
san francisco top stories
acetylon pharmaceuticals
ambys medicines
arrowmark partners
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
boston university
cell therapy
clinical trials
congenital hyperinsulinism
constellation pharmaceuticals
dacogen
decitabine
dexcom
diabetes
dna
drug delivery
edward damiano
eli lilly
epigenetics
epizyme
eventide asset management
farydak
fda
What
startup
3
×
biotech
developing
medicines
new
aiming
aims
ambys
approach
based
beta
big
bionics
blood
called
closed
control
deadly
deal
debuted
debuts
device
diabetes
diseases
driven
drugs
epigenetic
epigenetics
field
flagship’s
formed
future
heads
key
launch
levels
liver
make
manages
medical
Language
unset
Current search:
startup
×
vc
×
biotech
×
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
